JPRN-UMIN000021374已完成未知
Ex Vivo Expanded Erythroblast-Transplantation for patient with critical limb ischemia - EVEETA study
EVEETA Study Group0 个研究点目标入组 11 人开始时间: 2016年3月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 11
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with the expected rest of their life less than 1 year 2. Patients with drug dependence during the past 3 months 3. Patients with malignant evidence of malignant disorder during the past 5 years 4. Patients with poorly controlled diabetes mellitus accompanied with proliferative retinopathy 5. Patients with polycythemia; Hematcrit >55%(male), >50%(female) 6. Patients without informed consent 7. Pregnant or possibly pregnant females 8. Patients with acute myocardial infarction, unstable angina, myocarditis, or cerebral infarction during the past 1 month 9. Patients with active infection including Treponema pallidum, or positive test for Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) 10. Patients with history of allergy for antibiotics 11. Patients with anemia or thrombocytopenia 12. Patients judged inappropriate for this study by phisician 13. Patients without agreement for including in this study
研究者
相似试验
进行中（未招募）
不适用
Allogeneic Haematopoietic Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-Thymocyte Globulin for Patients with Refractory ?Triple Negative? Breast Cancer - NDPatients with Refractory ?Triple Negative? Breast CancerMedDRA version: 9.1Level: LLTClassification code 10006187Term: Breast cancerEUCTR2008-006262-28-ITISTITUTO EUROPEO DI ONCOLOGIA
未知
不适用
Peripheral blood mononuclear cell implantation for patients with severe ischemic heart diseaseSevere ischemic heart diseaseJPRN-UMIN000001289Department of Cardiovascular Science and Medicine,Graduate School of Medicine,Chiba University30
进行中（未招募）
不适用
Allogeneic Hematopoietic Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-Thymocyte Globulin for Patients with Hematologic Malignancies - NDPreparative Regimen of Total Lymphoid Irradiation and Anti-Thymocyte Globulin for Patients with Hematologic MalignanciesMedDRA version: 6.1Level: PTClassification code 10028228EUCTR2007-005563-10-ITFONDAZIONE NEOPLASIE SANGUE ONLUS
进行中（未招募）
不适用
onmyeloablative Hematopoietic Stem Cell Transplantation for Patients with High-Risk Hematologic Malignancies using Related, HLA-Haploidentical Donors: A Phase II Trial of Combined Immunosuppression with cyclophosfamide administered Before and After Transplantation. A monocentric study. - NDHigh risk Hematologic MalignanciesMedDRA version: 9.1Level: HLGTClassification code 10024324MedDRA version: 9.1Level: HLGTClassification code 10025323EUCTR2009-018083-94-ITISTITUTO EUROPEO DI ONCOLOGIA
招募中
1 期
Blood Stem Cell transplantation with low dose chemo/radiotherapy for patients with High-Risk solid tumors using related identical donors or 50% compatible donorsEUCTR2012-002464-27-ITISTITUTO EUROPEO DI ONCOLOGIA20